# FDA Inspection 668619 - Regenerative Sciences, LLC - June 16, 2010

Source: https://www.keypedia.com/records/fda_inspections/regenerative-sciences-llc/317ebc7a-3200-4ae9-b1fd-9ced144e461a
Source feed: FDA_Inspections

> FDA Inspection 668619 for Regenerative Sciences, LLC on June 16, 2010. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 668619
- Company Name: Regenerative Sciences, LLC
- Inspection Date: 2010-06-16
- Classification: Official Action Indicated (OAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 668619 - 2010-06-16](https://www.keypedia.com/records/fda_inspections/regenerative-sciences-llc/b2f12ba0-3086-4bb1-bc79-4adc11d03ed5)
- [FDA Inspection 577184 - 2009-04-15](https://www.keypedia.com/records/fda_inspections/regenerative-sciences-llc/33885362-c125-4b80-8cce-38e1c07dd902)
- [FDA Inspection 577184 - 2009-04-15](https://www.keypedia.com/records/fda_inspections/regenerative-sciences-llc/f03be7f8-eade-4a27-96cb-57232c6fc7a3)

Company: https://www.keypedia.com/companies/regenerative-sciences-llc/9f79d2cd-c588-4286-a2dc-c1d1a1303697

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d